FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: Taiwan's Agriculture Ministry Asks China to Restore Farm Imports

By

FINWIRES Analysis

Taipei's public framing of China as an unreliable, politically driven buyer signals a deliberate pivot to diversify agricultural exports away from cross-strait dependence. The selective Straits Forum purchases look more like political gestures than a durable trade reopening. The EU's opening to Taiwanese produce is the more strategically meaningful development to track for export resilience.

Key Takeaways

  • Taipei pushing diversification away from China reliance
  • Selective imports read as political gestures
  • EU market access is the structural opportunity

Taiwan's Ministry of Agriculture (MOA) urged China to resume imports of Taiwanese agricultural products in line with international trade rules and scientific standards, criticizing Beijing for selectively permitting some imports while maintaining bans on others, Taipei Times reported Monday.

The ministry's remarks came after an agreement signed at the Straits Forum in Xiamen over the weekend for China to buy Taiwanese atemoyas, pomelos, tea and groupers from Taitung, Yunlin and Nantou. The MOA said China has unilaterally suspended multiple Taiwanese agricultural and fishery imports since 2022 and ignored requests for sanitary and phytosanitary consultations, according to the report.

Taiwan said China's market cannot be considered reliable in the long term due to opaque approval processes and politically driven restrictions. The ministry added it is expanding exports to other markets, noting that the European Union recently opened its market to Taiwanese lychees and dragon fruit, with about 6.5 tonnes of Taiwanese fruit exported to Europe this month.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Singapore Regulator to Streamline 'Single Family Office' Framework

The Monetary Authority of Singapore has revised its "single family office" (SFOs) framework to streamline the process for SFOs to establish operations in Singapore, according to a MAS release.An SFO in Singapore is a privately held corporate entity set up by one "ultra-high-net-worth" family to manage assets, investments, and wealth of a single family.The registration protocols have been simplified, effective June 15, with offices required to notify MAS of their operations through a MAS-licensed bank.Annual reporting has been made more straightforward for SFOs, with information on total assets under management and the name of its bank.

^STI
Asia

Klevo Rewards Plans Stablecoin Trial Launch by June 30; Shares Fall 4%

Klevo Rewards (ASX:KLV) said it plans to launch a trial of its KLVAUD Australian dollar-backed stablecoin by June 30, according to a Monday filing with the Australian bourse.The company's Fly Wallet subsidiary received legal advice indicating that the stablecoin may qualify as an eligible stablecoin under the current regulatory framework, subject to conditions, per the filing.KLVAUD is planned to be fully backed one-to-one by Australian dollars held in segregated reserve accounts, and aims to support Fly Wallet's broader payments system, the company said.Klevo Rewards shares fell 4% in recent Monday trade.

ASX:KLV
Asia

Bio-Thera Solutions Gets Europe's Results on On-Site Inspection

Bio-Thera Solutions (SHA:688177) received the results of the European Union's inspection of its Yonghe manufacturing facility, according to a Shanghai bourse filing on Monday.The French National Agency for the Safety of Medicines and Health Products conducted an inspection on the site between Feb. 4 and Feb. 12.The European Medicines Agency handed a GMP or good manufacturing practice certificate to the company after the factory's drug substance operations passed regulatory standards. However, the regulator found deficiencies in the deviation management measures for the finished formulation of the drugs.

SHA:688177